Related Experiment Videos

Fatma Ali Tarish Mohsen1, Finn Friis Lauszus2, Marlene Briciet Lauritsen3

  • 1Det Sundhedsvidenskabelige Fakultet, Københavns Universitet.

Ugeskrift for Laeger
|November 4, 2022
PubMed

Insights

Gestational diabetes mellitus (GDM) increases a child's risk for autism spectrum disorder (ASD). Early GDM diagnosis in mothers further elevates this risk, highlighting the importance of timely intervention.

Area of Science:

  • Obstetrics and Gynecology
  • Developmental Pediatrics
  • Neurodevelopmental Disorders

Background:

  • Gestational diabetes mellitus (GDM) is a significant complication of pregnancy.
  • GDM is linked to various adverse child outcomes, but specific associations with developmental disorders require clarification.
  • Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with increasing prevalence.

Approach:

  • This review synthesizes current research on the association between maternal GDM and the risk of ASD in offspring.
  • Focuses on findings from large-scale cohort studies.
  • Summarizes the latest evidence regarding the timing of GDM diagnosis and its impact on ASD risk.

Key Points:

  • Large cohort studies demonstrate a statistically significant association between GDM and an increased risk of ASD in children.
  • The risk of developing ASD appears to be dose-dependent on GDM, with earlier maternal diagnosis correlating with higher risk.
  • This suggests a potential biological or environmental pathway linking GDM during pregnancy to neurodevelopmental trajectories.

Conclusions:

  • Maternal GDM is a confirmed risk factor for ASD in children.
  • The timing of GDM diagnosis during pregnancy is a critical factor influencing the magnitude of ASD risk.
  • Further research is warranted to elucidate the underlying mechanisms and inform preventative strategies.

Related Concept Videos